Results 81 to 90 of about 2,265,448 (242)
Aging impairs vaccine efficacy through gut microbiota dysbiosis and mTOR hyperactivation, which together drive inflammaging and weaken immune memory. This review highlights the bidirectional microbiota–mTOR axis and proposes that combining mTOR inhibitors with microbiota modulation offers a promising strategy to enhance vaccine responses in older ...
Jiaxuan Li +5 more
wiley +1 more source
Promising Inhibitor for 2019-nCoV in Drug Development
The 2019 novel coronavirus (2019-nCoV), which is first detected in Wuhan, China, is a virus identified as the cause of pneumonia. In the event of epidemic outbreak, a series of actions have taken by the Chinese government to control the pandemic of the ...
Zilong Dang, Xiaohui Xu
core +1 more source
ABSTRACT Regulatory instruments to manage the COVID‐19 pandemic have been the object of rich scholarly debates, primarily focused on early national responses to the crisis. We investigate variation in sub‐national regulatory approaches when a crisis is normalized, its association with competing political ideas about the health‐economy trade‐off and the
Salvador Parrado +3 more
wiley +1 more source
Wastewater surveillance results showed a 0–8 day early warning compared to clinical data depending on the type of virus that was investigated. ABSTRACT Wastewater‐based epidemiology (WBE) is increasingly transitioning from treatment plant scale monitoring toward community‐scale surveillance to provide higher spatial resolution.
Yuzhu Mao +5 more
wiley +1 more source
Abstract INTRODUCTION The COVID‐19 pandemic underscored the impact of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection on worsening the severity of Alzheimer's disease (AD) neuropathology and disease progression. METHODS Aged 5xFAD and wild‐type (WT) mice were infected with a mouse‐adapted SARS‐CoV‐2 (MA10), and extensive ...
Susana Furman +14 more
wiley +1 more source
COVID-2019: update on epidemiology, disease spread and management
With each passing day, more cases of Coronavirus disease (COVID-2019) are being detected and unfortunately the fear of novel corona virus 2019 (2019-nCoV) becoming a pandemic disease has come true.
Kamal Kant Sahu +2 more
doaj +1 more source
Transmission routes of 2019-nCoV and controls in dental practice
A novel β-coronavirus (2019-nCoV) caused severe and even fetal pneumonia explored in a seafood market of Wuhan city, Hubei province, China, and rapidly spread to other provinces of China and other countries. The 2019-nCoV was different from SARS-CoV, but
Li, Yuqing +11 more
core +1 more source
Our findings underscore a multi‐targeting strategy for severe airway inflammation that multi‐targeting nanoformulation C‐TA1 markedly attenuated airway inflammation by (1) cfDNA elimination to alleviate neutrophilic/eosinophilic inflammation mediated by the TLR9 pathway, (2) prevention of RONS‐induced tissue injury and inflammatory response, (3 ...
Ming Liu +10 more
wiley +1 more source
ABSTRACT Background and Aims Coronavirus disease‐2019 (COVID‐19) emerged in 2019 from Wuhan, China, leading to the accelerated development of vaccines, which have proven instrumental in controlling the spread of the virus. While vaccination ceased the increasing trend of the viral infection, rare adverse autoimmune events emerged as important ...
Mohammad Javad Yousefi‐Hashemabad +6 more
wiley +1 more source
CORONAVIRUS DISEASE 2019 (COVID-19)
The epidemic of 2019 novel coronavirus (2019-nCoV) has been emerged from a major city named Wuhan in the Hubei Province of China. It appears to have the potential to cause a major health problem globally. Earlier it is called 2019-nCoV but now this virus
Aysha Azhar
doaj +1 more source

